Navigation Links
Soligenix Reports First Quarter 2011 Financial Results and Reviews Accomplishments
Date:5/13/2011

PRINCETON, N.J., May 13, 2011 /PRNewswire/ -- Soligenix, Inc. (OTCBB: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company, announced today its financial results for the first quarter of 2011.

Soligenix's revenues for the first quarter of 2011 were approximately $808,000 as compared to $336,000 for the first quarter of 2010. The increased revenues were primarily a result of increases in National Institutes of Health (NIH) grant revenues as the Company increased research efforts under its thermostable vaccine development program and under its FDA Orphan Products grant for the confirmatory Phase 3 clinical trial of orBec® in acute gastrointestinal Graft-versus-Host disease (GI GVHD).

Soligenix's net loss for the first quarter of 2011 was approximately $1,720,000, or $(0.01) per share, as compared to $2,136,000, or $(0.01) per share for the first quarter of 2010.

Research and development expenses for the first quarter of 2011 were approximately $1,256,000, compared to $1,598,000 for the first quarter of 2010. General and administrative expenses for the first quarter of 2011 were approximately $564,000, compared to approximately $538,000 for the first quarter of 2010.

"While the first quarter of 2011 was quite eventful for us, our primary focus continues to be the conduct of our confirmatory Phase 3 orBec® clinical trial," stated Christopher J. Schaber, PhD, President and Chief Executive Officer of Soligenix. "We remain committed to our goal of having orBec® become the first FDA-approved therapy to treat GI GVHD, an area of unmet medical need associated with high morbidity and mortality rates. On the biodefense and vaccine side of our business, we received Orphan Drug designation for RiVax™ and also executed a license on new technology that will potentially enable us to develop vaccines that are stable at elevated temperatures. We also achieved positive results of SGX202 in a canine model of rad
'/>"/>

SOURCE Soligenix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Soligenix Reports Year-End 2010 Financial Results and Highlights Recent Accomplishments
2. Soligenix Receives FDA Orphan Drug Designation for RiVax™ for the Prevention of Ricin Intoxication
3. Soligenix Reports Second Quarter 2010 Financial Results and Reviews Accomplishments
4. Soligenix Announces Private Equity Financing of $5.16 Million With Its Partner Sigma-Tau and Other Institutional Investors
5. Soligenix Announces Grant of US Patent for the Treatment of Irritable Bowel Syndrome with Oral Beclomethasone Dipropionate
6. Soligenix Reports First Quarter 2010 Financial Results and Reviews Accomplishments
7. Soligenix Announces Completion of Patient Enrollment in Phase 2 Acute GVHD Prevention Clinical Trial
8. Soligenix Announces Grant of Broad European Patent for Topically Active Steroids to Treat Inflammatory Gastrointestinal Disorders
9. Soligenix to Present at 12th Annual BIO CEO & Investor Conference
10. Soligenix Reports Third Quarter 2009 Financial Results
11. Soligenix to Present at 8th Annual BIO Investor Forum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... A new research platform uses a laser ... structures undergoing stress and heating, an approach ... for microelectronics and batteries., This new technique, ... how heating and the surface stress of ... have discussed the merits of surface-stress influence ...
(Date:8/28/2014)... --  SunTrust Robinson Humphrey (STRH) today announced ... equity research team in biotechnology and oilfield services.  ... research demonstrates our commitment to providing our valued ... investment decision making," said Biff Woodruff , ... make significant investments in differentiated content at a ...
(Date:8/28/2014)... Woodstock, Vt. (PRWEB) August 28, 2014 ... microbiology testing around the world is available from ... industrial diagnostics companies. “ Industrial Microbiology Market Review, ... the Industrial Market ” (IMMR—4) tracks and compares ... in in North America, Europe and Asia, and ...
(Date:8/27/2014)... Lake City, Utah (PRWEB) August 27, 2014 ... construction that will expand its current Salt Lake City ... currently underway outside of Utah to ultimately create 1,000 ... next 20 years. , “Utah is home to ... of whom can be credited with Varian’s success in ...
Breaking Biology Technology:New analytical technology reveals 'nanomechanical' surface traits 2New analytical technology reveals 'nanomechanical' surface traits 3SunTrust Robinson Humphrey Expands Equity Research in Healthcare and Energy 2SunTrust Robinson Humphrey Expands Equity Research in Healthcare and Energy 32 Billion Industrial Microbiology Tests Conducted for Product Quality and Safety Worldwide 22 Billion Industrial Microbiology Tests Conducted for Product Quality and Safety Worldwide 3Varian Medical Systems Groundbreaking on Facility Expansion Triggers Influx of New Jobs to Salt Lake 2Varian Medical Systems Groundbreaking on Facility Expansion Triggers Influx of New Jobs to Salt Lake 3
... Impact on Families of von ... Willebrand Disease, NEW YORK, ... most common hereditary bleeding disorder, von,Willebrand disease (VWD), most don,t even know ... Centers for Disease Control and,Prevention (CDC) it takes a woman an average ...
... DIEGO, Sept. 23 Halozyme Therapeutics,Inc. (Nasdaq: ... targeting the extracellular matrix, today,announced that Douglas B. ... Endocrinology Clinical Development., "I am thrilled to ... achievement to the Halozyme leadership team. He is ...
... 85,000 Expected to Enroll in Phase 4 Study ... Wyeth Pharmaceuticals, a,division of Wyeth (NYSE: WYE ... Pneumonia Immunization Trial in Adults a major study ... to help,prevent pneumococcal pneumonia -- the leading cause ...
Cached Biology Technology:Video: Moms Raise 'Red Flag' About the Dangers of Widely Undiagnosed Bleeding Disorder 2Video: Moms Raise 'Red Flag' About the Dangers of Widely Undiagnosed Bleeding Disorder 3Video: Moms Raise 'Red Flag' About the Dangers of Widely Undiagnosed Bleeding Disorder 4Halozyme Therapeutics Appoints Head of Endocrinology Clinical Development 2Halozyme Therapeutics Appoints Head of Endocrinology Clinical Development 3Halozyme Therapeutics Appoints Head of Endocrinology Clinical Development 4Major Adult Vaccine Clinical Trial for Pneumonia Prevention Begins 2Major Adult Vaccine Clinical Trial for Pneumonia Prevention Begins 3Major Adult Vaccine Clinical Trial for Pneumonia Prevention Begins 4Major Adult Vaccine Clinical Trial for Pneumonia Prevention Begins 5
(Date:8/28/2014)... A Mayo Clinic researcher and his collaborators have developed ... enhance the process of re-engineering cells for biomedical investigation. ... biology methods to aid stem cell engineering. Details of ... described in two back-to-back papers in the journal ... range of uses for all types of cell-based investigations ...
(Date:8/28/2014)... , Aug. 28, 2014  Privacy Advocate and ... Jennifer Lynch , joins the lineup of biometric ... second annual Biometrics UnPlugged Executive Summit in ... Previously announced speakers include Steven Rahman, Director, Technology ... Public Sector at Experian. The theme of this year,s ...
(Date:8/28/2014)... the most commonly diagnosed learning disability in the ... occurs when the regions of the brain that ... use of non-invasive functional neuroimaging tools has helped ... However, most prior work has focused on only ... gap in our understanding of how multiple brain ...
Breaking Biology News(10 mins):New tool aids stem cell engineering for medical research 2Biometrics UnPlugged Welcomes the Electronic Frontier Foundation's Jennifer Lynch to the Mobility at the Crossroads of Commerce and Privacy Summit 2Dyslexic readers have disrupted network connections in the brain 2
... clams to flying creatures like hummingbirds and bats, many ... flow. When the 61st Annual Meeting of the American ... from November 23-25 at the San Antonio Convention Center, ... with applications in astronomy, engineering, alternative energy, biology, and ...
... University] Imagine yourself swimming in a pool: It,s the ... the water, that mostly dictates the speed and direction that ... Microbes, speed and direction are subjected more to the physical ... swim in water," explained Jay Tang, associate professor of physics ...
... land use patterns and increasing pressures on water ... management focuses on regulating the flow of runoff ... the hydrologic cycle disrupted by extensive pavement and ... of infiltration opportunities affects groundwater recharge and has ...
Cached Biology News:Animal and biological science highlights: San Antonio Fluid Dynamics Conference, Nov. 23-25 2Animal and biological science highlights: San Antonio Fluid Dynamics Conference, Nov. 23-25 3Animal and biological science highlights: San Antonio Fluid Dynamics Conference, Nov. 23-25 4Animal and biological science highlights: San Antonio Fluid Dynamics Conference, Nov. 23-25 5Animal and biological science highlights: San Antonio Fluid Dynamics Conference, Nov. 23-25 6Animal and biological science highlights: San Antonio Fluid Dynamics Conference, Nov. 23-25 7Animal and biological science highlights: San Antonio Fluid Dynamics Conference, Nov. 23-25 8How do bacteria swim? Brown physicists explain 2Urban trees enhance water infiltration 2
... GenomePlex Single Cell Whole Genome Amplification ... on random fragmentation of genomic DNA ... fragments to PCR-amplifiable library molecules flanked ... achieved by PCR amplification of the ...
...
From formula-fed bovine calves Sterile, Cell culture tested...
Collected at a certified USDA establishment located within the United States. All final processing is done by Quad Five employees....
Biology Products: